New pill combo could replace chemo for rare blood cancer
NCT ID NCT05099471
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 20 times
Summary
This study tests whether a combination of two drugs, venetoclax and rituximab, works better than standard chemotherapy for people with untreated Waldenström's macroglobulinemia, a rare blood cancer. About 80 participants will receive either the drug combo or chemo, and researchers will measure how well the cancer responds after 12 months. The goal is to find a more effective, fixed-duration treatment that avoids the need for lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM MACROGLOBULINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alexandra Hospital
RECRUITINGAthens, 115 28, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dr. Vehling-Kaiser MVZ GmbH
RECRUITINGLandshut, 84036, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gemeinschaftsklinikum Mittelrhein gGmbH
RECRUITINGKoblenz, 56073, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Haematologie und Onkologie Muenchen-Pasing MVZ GmbH
RECRUITINGMünchen, 81241, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kliniken Maria Hilf GmbH Moenchengladbach
RECRUITINGMönchengladbach, 41063, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Klinikum Chemnitz gGmbH
RECRUITINGChemnitz, 09116, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Klinikverbund Allgaeu gGmbH
RECRUITINGKempten, 87439, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Onkologische Schwerpunktpraxis Bielefeld
RECRUITINGBielefeld, 33604, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitaet Muenster
RECRUITINGMünster, 48149, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitaetsklinikum Schleswig-Holstein AöR
NOT_YET_RECRUITINGKiel, 24105, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Ulm
RECRUITINGUlm, 89081, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.